Cel-Sci is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Geert R. Kersten, with a market cap of $36.2M.
Common questions about Cel-Sci
Cel-Sci is scheduled to report earnings for Q2 2026 on May 14, 2026.
Cel-Sci has approximately 44 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.